Cargando…

Effectiveness of three delivery models for promoting access to pre-exposure prophylaxis in HIV-1 serodiscordant couples in Nigeria

OBJECTIVES: To evaluate the effectiveness of three models for pre-exposure prophylaxis (PrEP) service delivery to HIV-1 serodiscordant couples in Nigeria. METHODS: 297 heterosexual HIV-1 serodiscordant couples were recruited into three PrEP delivery models and followed up for 18 months. The models w...

Descripción completa

Detalles Bibliográficos
Autores principales: Folayan, Morenike Oluwatoyin, Aliyu, Sani, Oginni, Ayodeji, Ezechi, Oliver, Kolawole, Grace, Ezeama, Nkiru, Dadem, Nancin, Anenih, James, Alagi, Matthias, Ekanem, Etim, Afiadigwe, Evaristus, Aguolu, Rose, Oyebode, Tinuade, Babalola-Jacobs, Alero, Sagay, Atiene, Nweneka, Chidi, Kamofu, Hadiza, Idoko, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9070899/
https://www.ncbi.nlm.nih.gov/pubmed/35511948
http://dx.doi.org/10.1371/journal.pone.0268011
_version_ 1784700731264073728
author Folayan, Morenike Oluwatoyin
Aliyu, Sani
Oginni, Ayodeji
Ezechi, Oliver
Kolawole, Grace
Ezeama, Nkiru
Dadem, Nancin
Anenih, James
Alagi, Matthias
Ekanem, Etim
Afiadigwe, Evaristus
Aguolu, Rose
Oyebode, Tinuade
Babalola-Jacobs, Alero
Sagay, Atiene
Nweneka, Chidi
Kamofu, Hadiza
Idoko, John
author_facet Folayan, Morenike Oluwatoyin
Aliyu, Sani
Oginni, Ayodeji
Ezechi, Oliver
Kolawole, Grace
Ezeama, Nkiru
Dadem, Nancin
Anenih, James
Alagi, Matthias
Ekanem, Etim
Afiadigwe, Evaristus
Aguolu, Rose
Oyebode, Tinuade
Babalola-Jacobs, Alero
Sagay, Atiene
Nweneka, Chidi
Kamofu, Hadiza
Idoko, John
author_sort Folayan, Morenike Oluwatoyin
collection PubMed
description OBJECTIVES: To evaluate the effectiveness of three models for pre-exposure prophylaxis (PrEP) service delivery to HIV-1 serodiscordant couples in Nigeria. METHODS: 297 heterosexual HIV-1 serodiscordant couples were recruited into three PrEP delivery models and followed up for 18 months. The models were i) Outpatient clinic model providing PreP in routine outpatient care; ii) Antiretroviral therapy (ART) clinic model providing PrEP in ART clinics; and iii) Decentralized care model providing PrEP through primary and secondary care centres linked to a tertiary care centre. The primary effectiveness endpoint was incident HIV-1 infection. The HIV incidence before and after the study was compared and the incidence rate ratio computed for each model. Survival analysis was conducted, Cox regression analysis was used to compare the factors that influenced couple retention in each of the models. Kaplan-Meier survival analysis was used to estimate the median retention time (in months) of the study participants in each of the study models, and log-rank test for equality of survival functions was conducted to test for significant differences among the three models. RESULTS: There was no significant difference (p>0.05) in the couple retention rates among the three models. At months 3, 6 and 9, adherence of the HIV-1-infected partners to ART was highest in the decentralized model, whereas at months 9 and 12, the outpatient model had the highest proportion of HIV-1- uninfected partners adhering to PrEP (p<0.001). The HIV incidence per 100 person-years was zero in the general outpatient clinic and ART clinic models and 1.6 (95% CI: 0.04–9.1) in the decentralized clinic model. The difference in the observed and expected incidence rate was 4.3 (95% CI: 0.44–39.57) for the decentralized clinic model. CONCLUSION: Although incidence of HIV seroconversion was highest in the decentralized clinic model, this difference may be due to the higher sexual risk behavior among study participants in the decentralized model rather than the type of service delivery. The study findings imply that any of the models can effectively deliver PrEP services.
format Online
Article
Text
id pubmed-9070899
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-90708992022-05-06 Effectiveness of three delivery models for promoting access to pre-exposure prophylaxis in HIV-1 serodiscordant couples in Nigeria Folayan, Morenike Oluwatoyin Aliyu, Sani Oginni, Ayodeji Ezechi, Oliver Kolawole, Grace Ezeama, Nkiru Dadem, Nancin Anenih, James Alagi, Matthias Ekanem, Etim Afiadigwe, Evaristus Aguolu, Rose Oyebode, Tinuade Babalola-Jacobs, Alero Sagay, Atiene Nweneka, Chidi Kamofu, Hadiza Idoko, John PLoS One Research Article OBJECTIVES: To evaluate the effectiveness of three models for pre-exposure prophylaxis (PrEP) service delivery to HIV-1 serodiscordant couples in Nigeria. METHODS: 297 heterosexual HIV-1 serodiscordant couples were recruited into three PrEP delivery models and followed up for 18 months. The models were i) Outpatient clinic model providing PreP in routine outpatient care; ii) Antiretroviral therapy (ART) clinic model providing PrEP in ART clinics; and iii) Decentralized care model providing PrEP through primary and secondary care centres linked to a tertiary care centre. The primary effectiveness endpoint was incident HIV-1 infection. The HIV incidence before and after the study was compared and the incidence rate ratio computed for each model. Survival analysis was conducted, Cox regression analysis was used to compare the factors that influenced couple retention in each of the models. Kaplan-Meier survival analysis was used to estimate the median retention time (in months) of the study participants in each of the study models, and log-rank test for equality of survival functions was conducted to test for significant differences among the three models. RESULTS: There was no significant difference (p>0.05) in the couple retention rates among the three models. At months 3, 6 and 9, adherence of the HIV-1-infected partners to ART was highest in the decentralized model, whereas at months 9 and 12, the outpatient model had the highest proportion of HIV-1- uninfected partners adhering to PrEP (p<0.001). The HIV incidence per 100 person-years was zero in the general outpatient clinic and ART clinic models and 1.6 (95% CI: 0.04–9.1) in the decentralized clinic model. The difference in the observed and expected incidence rate was 4.3 (95% CI: 0.44–39.57) for the decentralized clinic model. CONCLUSION: Although incidence of HIV seroconversion was highest in the decentralized clinic model, this difference may be due to the higher sexual risk behavior among study participants in the decentralized model rather than the type of service delivery. The study findings imply that any of the models can effectively deliver PrEP services. Public Library of Science 2022-05-05 /pmc/articles/PMC9070899/ /pubmed/35511948 http://dx.doi.org/10.1371/journal.pone.0268011 Text en © 2022 Folayan et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Folayan, Morenike Oluwatoyin
Aliyu, Sani
Oginni, Ayodeji
Ezechi, Oliver
Kolawole, Grace
Ezeama, Nkiru
Dadem, Nancin
Anenih, James
Alagi, Matthias
Ekanem, Etim
Afiadigwe, Evaristus
Aguolu, Rose
Oyebode, Tinuade
Babalola-Jacobs, Alero
Sagay, Atiene
Nweneka, Chidi
Kamofu, Hadiza
Idoko, John
Effectiveness of three delivery models for promoting access to pre-exposure prophylaxis in HIV-1 serodiscordant couples in Nigeria
title Effectiveness of three delivery models for promoting access to pre-exposure prophylaxis in HIV-1 serodiscordant couples in Nigeria
title_full Effectiveness of three delivery models for promoting access to pre-exposure prophylaxis in HIV-1 serodiscordant couples in Nigeria
title_fullStr Effectiveness of three delivery models for promoting access to pre-exposure prophylaxis in HIV-1 serodiscordant couples in Nigeria
title_full_unstemmed Effectiveness of three delivery models for promoting access to pre-exposure prophylaxis in HIV-1 serodiscordant couples in Nigeria
title_short Effectiveness of three delivery models for promoting access to pre-exposure prophylaxis in HIV-1 serodiscordant couples in Nigeria
title_sort effectiveness of three delivery models for promoting access to pre-exposure prophylaxis in hiv-1 serodiscordant couples in nigeria
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9070899/
https://www.ncbi.nlm.nih.gov/pubmed/35511948
http://dx.doi.org/10.1371/journal.pone.0268011
work_keys_str_mv AT folayanmorenikeoluwatoyin effectivenessofthreedeliverymodelsforpromotingaccesstopreexposureprophylaxisinhiv1serodiscordantcouplesinnigeria
AT aliyusani effectivenessofthreedeliverymodelsforpromotingaccesstopreexposureprophylaxisinhiv1serodiscordantcouplesinnigeria
AT oginniayodeji effectivenessofthreedeliverymodelsforpromotingaccesstopreexposureprophylaxisinhiv1serodiscordantcouplesinnigeria
AT ezechioliver effectivenessofthreedeliverymodelsforpromotingaccesstopreexposureprophylaxisinhiv1serodiscordantcouplesinnigeria
AT kolawolegrace effectivenessofthreedeliverymodelsforpromotingaccesstopreexposureprophylaxisinhiv1serodiscordantcouplesinnigeria
AT ezeamankiru effectivenessofthreedeliverymodelsforpromotingaccesstopreexposureprophylaxisinhiv1serodiscordantcouplesinnigeria
AT dademnancin effectivenessofthreedeliverymodelsforpromotingaccesstopreexposureprophylaxisinhiv1serodiscordantcouplesinnigeria
AT anenihjames effectivenessofthreedeliverymodelsforpromotingaccesstopreexposureprophylaxisinhiv1serodiscordantcouplesinnigeria
AT alagimatthias effectivenessofthreedeliverymodelsforpromotingaccesstopreexposureprophylaxisinhiv1serodiscordantcouplesinnigeria
AT ekanemetim effectivenessofthreedeliverymodelsforpromotingaccesstopreexposureprophylaxisinhiv1serodiscordantcouplesinnigeria
AT afiadigweevaristus effectivenessofthreedeliverymodelsforpromotingaccesstopreexposureprophylaxisinhiv1serodiscordantcouplesinnigeria
AT aguolurose effectivenessofthreedeliverymodelsforpromotingaccesstopreexposureprophylaxisinhiv1serodiscordantcouplesinnigeria
AT oyebodetinuade effectivenessofthreedeliverymodelsforpromotingaccesstopreexposureprophylaxisinhiv1serodiscordantcouplesinnigeria
AT babalolajacobsalero effectivenessofthreedeliverymodelsforpromotingaccesstopreexposureprophylaxisinhiv1serodiscordantcouplesinnigeria
AT sagayatiene effectivenessofthreedeliverymodelsforpromotingaccesstopreexposureprophylaxisinhiv1serodiscordantcouplesinnigeria
AT nwenekachidi effectivenessofthreedeliverymodelsforpromotingaccesstopreexposureprophylaxisinhiv1serodiscordantcouplesinnigeria
AT kamofuhadiza effectivenessofthreedeliverymodelsforpromotingaccesstopreexposureprophylaxisinhiv1serodiscordantcouplesinnigeria
AT idokojohn effectivenessofthreedeliverymodelsforpromotingaccesstopreexposureprophylaxisinhiv1serodiscordantcouplesinnigeria